Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease

Alzheimer's and Dementia: Translational Research and Clinical Interventions

Volumn 4, Issue , 2018, Pages 28-36

  Taylor, Matthew K ^a   Sullivan, Debra K ^a   Mahnken, Jonathan D ^a,b   Burns, Jeffrey M ^a,b   Swerdlow, Russell H ^a,b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Cognition; Ketogenic diet; Low carbohydrate diet; Medium chain triglyceride

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLINESTERASE INHIBITOR; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MEDIUM CHAIN TRIACYLGLYCEROL;

ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE COGNITIVE SUBSCALE; ARTICLE; BODY MASS; CAREGIVER BURDEN; CLINICAL ARTICLE; CLINICAL DEMENTIA RATING; CONTROLLED STUDY; DEMENTIA ASSESSMENT; DIETARY INTAKE; FEASIBILITY STUDY; FEMALE; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; KETOACIDOSIS; KETOGENIC DIET; KETONURIA; MALE; MINI MENTAL STATE EXAMINATION; PILOT STUDY; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE;

EID: 85040337774     PISSN: None     EISSN: 23528737     Source Type: Journal    
DOI: 10.1016/j.trci.2017.11.002     Document Type: Article

References (42)

1. Swerdlow, R.H., Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease. Antioxid Redox Signal 16 (2012), 1434–1455.
2. De Santi, S., de Leon, M.J., Convit, A., Tarshish, C., Rusinek, H., Tsui, W.H., et al. Age-related changes in brain: II. Positron emission tomography of frontal and temporal lobe glucose metabolism in normal subjects. Psychiatr Q 66 (1995), 357–370.
3. Nugent, S., Tremblay, S., Chen, K.W., Ayutyanont, N., Roontiva, A., Castellano, C.A., et al. Brain glucose and acetoacetate metabolism: a comparison of young and older adults. Neurobiol Aging 35 (2014), 1386–1395.
4. Ferris, S.H., de Leon, M.J., Wolf, A.P., Farkas, T., Christman, D.R., Reisberg, B., et al. Positron emission tomography in the study of aging and senile dementia. Neurobiol Aging 1 (1980), 127–131.
5. Foster, N.L., Chase, T.N., Fedio, P., Patronas, N.J., Brooks, R.A., Di Chiro, G., Alzheimer's disease: focal cortical changes shown by positron emission tomography. Neurology 33 (1983), 961–965.
6. Reiman, E.M., Caselli, R.J., Yun, L.S., Chen, K., Bandy, D., Minoshima, S., et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 334 (1996), 752–758.
7. Small, G.W., Mazziotta, J.C., Collins, M.T., Baxter, L.R., Phelps, M.E., Mandelkern, M.A., et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 273 (1995), 942–947.
8. Mosconi, L., Brys, M., Switalski, R., Mistur, R., Glodzik, L., Pirraglia, E., et al. Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism. Proc Natl Acad Sci U S A 104 (2007), 19067–19072.
9. Swerdlow, R., Marcus, D.L., Landman, J., Kooby, D., Frey, W. 2nd, Freedman, M.L., Brain glucose metabolism in Alzheimer's disease. Am J Med Sci 308 (1994), 141–144.
10. Swerdlow, R.H., Bioenergetic medicine. Br J Pharmacol 171 (2014), 1854–1869.
11. Kossoff, E.H., Zupec-Kania, B.A., Rho, J.M., Ketogenic diets: an update for child neurologists. J Child Neurol 24 (2009), 979–988.
12. Owen, O.E., Morgan, A.P., Kemp, H.G., Sullivan, J.M., Herrera, M.G., Cahill, G.F. Jr., Brain metabolism during fasting. J Clin Invest 46 (1967), 1589–1595.
13. Edmond, J., Robbins, R.A., Bergstrom, J.D., Cole, R.A., de Vellis, J., Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture. J Neurosci Res 18 (1987), 551–561.
14. Hasselbalch, S.G., Knudsen, G.M., Jakobsen, J., Hageman, L.P., Holm, S., Paulson, O.B., Blood-brain barrier permeability of glucose and ketone bodies during short-term starvation in humans. Am J Physiol 268 (1995), E1161–E1166.
15. Cunnane, S.C., Courchesne-Loyer, A., Vandenberghe, C., St-Pierre, V., Fortier, M., Hennebelle, M., et al. Can ketones help rescue brain fuel supply in later life? Implications for cognitive health during aging and the treatment of Alzheimer's disease. Front Mol Neurosci, 9, 2016, 53.
16. Castellano, C.A., Nugent, S., Paquet, N., Tremblay, S., Bocti, C., Lacombe, G., et al. Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia. J Alzheimers Dis 43 (2015), 1343–1353.
17. Swerdlow, R., Marcus, D.M., Landman, J., Harooni, M., Freedman, M.L., Brain glucose and ketone body metabolism in patients with Alzheimer's disease. Clin Res, 37, 1989, 461A.
18. Witte, A.V., Fobker, M., Gellner, R., Knecht, S., Floel, A., Caloric restriction improves memory in elderly humans. Proc Natl Acad Sci U S A 106 (2009), 1255–1260.
19. Krikorian, R., Shidler, M.D., Dangelo, K., Couch, S.C., Benoit, S.C., Clegg, D.J., Dietary ketosis enhances memory in mild cognitive impairment. Neurobiol Aging 33 (2012), 425.e19–425.e27.
20. Ota, M., Matsuo, J., Ishida, I., Hattori, K., Teraishi, T., Tonouchi, H., et al. Effect of a ketogenic meal on cognitive function in elderly adults: potential for cognitive enhancement. Psychopharmacology (Berl) 233 (2016), 3797–3802.
21. Reger, M.A., Henderson, S.T., Hale, C., Cholerton, B., Baker, L.D., Watson, G.S., et al. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging 25 (2004), 311–314.
22. Henderson, S.T., Vogel, J.L., Barr, L.J., Garvin, F., Jones, J.J., Costantini, L.C., Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond), 6, 2009, 31.
23. McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack, C.R. Jr., Kawas, C.H., et al. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7 (2011), 263–269.
24. Mifflin, M.D., St Jeor, S.T., Hill, L.A., Scott, B.J., Daugherty, S.A., Koh, Y.O., A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 51 (1990), 241–247.
25. Cervenka, M.C., Henry, B.J., Felton, E.A., Patton, K., Kossoff, E.H., Establishing an Adult Epilepsy Diet Center: Experience, efficacy and challenges. Epilepsy Behav 58 (2016), 61–68.
26. Mosek, A., Natour, H., Neufeld, M.Y., Shiff, Y., Vaisman, N., Ketogenic diet treatment in adults with refractory epilepsy: a prospective pilot study. Seizure 18 (2009), 30–33.
27. Yu, H., Wang, X., He, R., Liang, R., Zhou, L., Measuring the caregiver burden of caring for community-residing people with Alzheimer's disease. PLoS One, 10, 2015, e0132168.
28. Neal, E.G., Chaffe, H., Schwartz, R.H., Lawson, M.S., Edwards, N., Fitzsimmons, G., et al. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia 50 (2009), 1109–1117.
29. Lin, A.L., Zhang, W., Gao, X., Watts, L., Caloric restriction increases ketone bodies metabolism and preserves blood flow in aging brain. Neurobiol Aging 36 (2015), 2296–2303.
30. Newport, M.T., VanItallie, T.B., Kashiwaya, Y., King, M.T., Veech, R.L., A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer's disease. Alzheimers Dement 11 (2015), 99–103.
31. Puchalska, P., Crawford, P.A., Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab 25 (2017), 262–284.
32. Selfridge, J.E., Wilkins, H.M., Lezi, E., Carl, S.M., Koppel, S., Funk, E., et al. Effect of one month duration ketogenic and non-ketogenic high fat diets on mouse brain bioenergetic infrastructure. J Bioenerg Biomembr 47 (2015), 1–11.
33. Dupuis, N., Curatolo, N., Benoist, J.F., Auvin, S., Ketogenic diet exhibits anti-inflammatory properties. Epilepsia 56 (2015), e95–e98.
34. McDaniel, S.S., Rensing, N.R., Thio, L.L., Yamada, K.A., Wong, M., The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. Epilepsia 52 (2011), e7–e11.
35. Bough, K.J., Wetherington, J., Hassel, B., Pare, J.F., Gawryluk, J.W., Greene, J.G., et al. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol 60 (2006), 223–235.
36. Hartman, A.L., Gasior, M., Vining, E.P., Rogawski, M.A., The neuropharmacology of the ketogenic diet. Pediatr Neurol 36 (2007), 281–292.
37. Noh, H.S., Lee, H.P., Kim, D.W., Kang, S.S., Cho, G.J., Rho, J.M., et al. A cDNA microarray analysis of gene expression profiles in rat hippocampus following a ketogenic diet. Brain Res Mol Brain Res 129 (2004), 80–87.
38. Guzman, M., Blazquez, C., Is there an astrocyte-neuron ketone body shuttle?. Trends Endocrinol Metab 12 (2001), 169–173.
39. Newman, J.C., Verdin, E., β-hydroxybutyrate: much more than a metabolite. Diabetes Res Clin Pract 106 (2014), 173–181.
40. Menzies, K.J., Zhang, H., Katsyuba, E., Auwerx, J., Protein acetylation in metabolism - metabolites and cofactors. Nat Rev Endocrinol 12 (2016), 43–60.
41. Xie, Z., Zhang, D., Chung, D., Tang, Z., Huang, H., Dai, L., et al. Metabolic regulation of gene expression by histone lysine beta-hydroxybutyrylation. Mol Cell 62 (2016), 194–206.
42. Cullingford, T.E., The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders. Prostaglandins Leukot Essent Fatty Acids 70 (2004), 253–264.